CL stock, with 12% returns since the beginning of 2024, has underperformed the S&P 500 index, up 27%. The strengthening of ...
Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected ...
Raymond James lowered the firm’s price target on Colgate-Palmolive (CL) to $105 from $110 and keeps an Outperform rating on the shares. The ...
X added seven companies to its lawsuit Saturday, alleging they partook in a World Federation of Advertisers-coordinated (WFA) ...
Toothpaste maker Colgate-Palmolive forecast annual sales below Wall Street expectations after missing quarterly sales ...
Evercore ISI lowered the firm’s price target on Colgate-Palmolive (CL) to $100 from $105 and keeps an Outperform rating on the shares. Shares ...
Elon Musk’s X is adding several more companies to its lawsuit accusing firms of conspiring in an advertising “boycott” on the ...
Colgate Palmolive is looking at ways to reduce the impact of possible tariffs on its toothpastes, which the company ...
Elon Musk's X is suing more companies, alleging they joined a group of advertisers illegally conspiring to boycott the social ...
Colgate-Palmolive CEO Noel Wallace highlighted intense discounting wars among consumer goods companies in India due to ...
This, in turn, made X "a less effective competitor to other social media platforms in the sale of digital advertising and in ...
Colgate-Palmolive (NYSE:CL), a global leader in consumer products with a "GOOD" InvestingPro Financial Health score of 2.73, finds itself at a crossroads as it navigates a complex market environment.